Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Hopes for AIDS Vaccine Still Alive Despite Setbacks


Related Encyclopedia
 border=
Abscess
Acne
Actinomycosis
Acute Myeloid Leukemia (Adult)
More...

Related Healthscout Videos
 border=
Weighted Belt for Autism?
Teaching Old Docs New Tricks
Lead in Soil.
Pet Rehab
More...

Related Animations
 border=
Dental Cavities
Erectile Dysfunction
Menopause
More...

Related Drug Information
 border=
Abilify
Adderal XR
Augmentin
Bactroban Cream
More...

Related News Articles
 border=
Health Tip: Nails Can Reveal Your Health
Folate Levels in Pregnancy Tied to ADHD in Offspring
CDC Study Links 2 Antibiotics to Birth Defects
Severe Swine Flu Can Kill Young, Old Alike
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

A broadly protective vaccine would be tested against "very different strains than the strains used to make the vaccine," Gallo explained. "None of that had been done before the clinical trials that have been in the press."

Still, it's a daunting task considering that the variety of viral strains circulating in a single infected human body exceeds the variety of flu strains circulating globally each year, according to Wayne Koff, senior vice president of research and development at the International AIDS Vaccine Initiative (IAVI), based in New York City.

According to Koff, a good AIDS vaccine's reach "needs to be broad to be able to tackle whatever isolate of HIV the individual happens to be exposed to."

Text Continues Below



Vaccines work in two key ways. First, they prime the body's immune cells to recognize proteins on the virus' surface so they can be identified and destroyed. This "neutralizing antibody" effect typically eliminates all but a fraction of invading virus.

But a remnant of virus will still get through, infecting human cells. That's where a second arm of vaccination, called the "cell-mediated" response, comes in. This involves the mobilization of immune T-cells that seek out and destroy infected cells.

Any viable vaccine must wipe out the virus quickly and completely, Koff explained, "So, we need each of these two arms primed and ready for when you get exposed to HIV."

But there's yet one more hurdle unique to HIV. Unlike standard flu or cold viruses, HIV -- a more primitive retrovirus -- actually inserts a piece of its DNA into the genome of the human host cell.

This "integration" begins within hours or days of infection, mainly in the lymphoid tissues of the gut, and lasts a lifetime. Using these cells as a base, HIV can then amplify and mount an attack at any time.

"This means that both antibodies and activated T-cells will have to be [targeted] to where the virus is amplifying early," Koff said. "If we don't get it then, and it seeds other lymphoid organs in the body, then from a vaccine point of view, the party's over."

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 12/1/2008

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Wayne Koff, Ph.D., senior vice president, research and development, International AIDS Vaccine Initiative, New York City; Robert Gallo, M.D., director, Institute of Human Virology, University of Maryland School of Medicine, Baltimore; Rowena Johnston, Ph.D., vice president, research, Foundation for AIDS Research (amFAR), New York City


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy